2q5h
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2q5h. | + | {{Seed}} |
+ | [[Image:2q5h.png|left|200px]] | ||
<!-- | <!-- | ||
Line 9: | Line 10: | ||
{{STRUCTURE_2q5h| PDB=2q5h | SCENE= }} | {{STRUCTURE_2q5h| PDB=2q5h | SCENE= }} | ||
- | + | ===Crystal structure of apo-wildtype Glycyl-tRNA synthetase=== | |
- | + | <!-- | |
- | + | The line below this paragraph, {{ABSTRACT_PUBMED_17544401}}, adds the Publication Abstract to the page | |
+ | (as it appears on PubMed at http://www.pubmed.gov), where 17544401 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_17544401}} | ||
==Disease== | ==Disease== | ||
Line 39: | Line 43: | ||
[[Category: Oxford protein production facility]] | [[Category: Oxford protein production facility]] | ||
[[Category: Structural genomic]] | [[Category: Structural genomic]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
+ | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 04:47:56 2008'' |
Revision as of 01:48, 29 July 2008
Contents |
Crystal structure of apo-wildtype Glycyl-tRNA synthetase
Template:ABSTRACT PUBMED 17544401
Disease
Known disease associated with this structure: Charcot-Marie-Tooth disease, type 2D OMIM:[600287], Neuropathy, distal hereditary motor, type V OMIM:[600287]
About this Structure
2Q5H is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy., Cader MZ, Ren J, James PA, Bird LE, Talbot K, Stammers DK, FEBS Lett. 2007 Jun 26;581(16):2959-64. Epub 2007 May 29. PMID:17544401
Page seeded by OCA on Tue Jul 29 04:47:56 2008
Categories: Glycine--tRNA ligase | Homo sapiens | Single protein | Bird, L E. | Cader, M Z. | James, P A. | OPPF, Oxford Protein Production Facility. | Ren, J. | Stammers, D K. | Talbot, K. | Aminoacyl-trna synthetase | Atp-binding | Glycyl-trna synthetase | Oppf | Oxford protein production facility | Structural genomic